Literature DB >> 30040217

Quantitative Intracerebral Microdialysis Studies to Determine Unbound Extracellular Fluid Drug Concentrations in Discrete Areas of the Brain.

Matthew R Durk1.   

Abstract

Intracerebral microdialysis is a powerful technique for quantifying unbound brain extracellular fluid concentrations of drugs and drug candidates over time in live, conscious, freely moving animals. The results provide crucial information on the brain penetrance of the administered agent. This unit details the surgical procedures, study planning and execution, and data analysis required for a brain microdialysis study following intravenous infusion of a test substance to steady state. The accumulated data makes possible the determination of the area under the concentration-time curve ratio and steady-state concentration ratio for unbound compound in rat brain extracellular fluid as compared to that in plasma (Kpu,u ). In vitro determination of the compound recovery from the probe, a critical parameter in a microdialysis study, is considered as well.
© 2018 by John Wiley & Sons, Inc. © 2018 John Wiley & Sons, Inc.

Entities:  

Keywords:  brain; microdialysis; pharmacokinetics

Mesh:

Substances:

Year:  2018        PMID: 30040217     DOI: 10.1002/cpph.38

Source DB:  PubMed          Journal:  Curr Protoc Pharmacol        ISSN: 1934-8282


  2 in total

1.  A novel microemulsion-based isotonic perfusate modulated by Ringer's solution for improved microdialysis recovery of liposoluble substances.

Authors:  Yong-Tai Zhang; Zhi Wang; Li-Na Shen; Yan-Yan Li; Ze-Hui He; Qing Xia; Nian-Ping Feng
Journal:  J Nanobiotechnology       Date:  2018-11-14       Impact factor: 10.435

2.  Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium's first workshop on CNS drug delivery.

Authors:  Stuart A Grossman; Carlos G Romo; Michelle A Rudek; Jeffrey Supko; Joy Fisher; L Burt Nabors; Patrick Y Wen; David M Peereboom; Benjamin M Ellingson; William Elmquist; Fred G Barker; David Kamson; Jann N Sarkaria; William Timmer; Ranjit S Bindra; Xiaobu Ye
Journal:  Neuro Oncol       Date:  2020-10-14       Impact factor: 12.300

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.